Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.46 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | XBP1 | P17861 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL30397166 | 1.00 | HSPA5 (0.53) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL537648 | 0.97 | HSPA5 (0.53) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL7731612 | 0.97 | HSPA5 (0.53) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL7731846 | 0.97 | HSPA5 (0.53) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL7732345 | 0.97 | HSPA5 (0.53) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL537656 | 0.90 | HSPA5 (0.56) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL29500375 | 0.88 | HSPA5 (0.66) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL30903568 | 0.88 | HSPA5 (0.66) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL39554 | 0.88 | HSPA5 (0.66) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 | |
| SCHEMBL538260 | 0.87 | HSPA5 (0.44) | HSPA5CYP2C19CYP2C9HIF1ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9309408-B2 | Additive concentrate and use thereof | HOLLAND COLOURS N.V. (NL) | 2016-04-12 | — | — | US | claimed |
| US-20140353550-A1 | ADDITIVE CONCENTRATE AND USE THEREOF | HOLLAND COLOURS N.V. (NL) | 2014-12-04 | — | — | US | claimed |
| EP-2559726-B1 | Additive concentrate and use thereof | HOLLAND COLOURS NV (NL) | 2014-02-19 | — | — | EP | claimed |
| WO-2013025098-A1 | ADDITIVE CONCENTRATE AND USE THEREOF | HOLLAND COLOURS N.V. (NL) | 2013-02-21 | — | — | WO | claimed |
| EP-2559726-A1 | Additive concentrate and use thereof | Holland Colours N. V. (NL) | 2013-02-20 | — | — | EP | claimed |
| EP-1694368-B1 | TERMINAL STERILIZATION OF PREFILLED CONTAINERS | BECTON DICKINSON CO (US) | 2012-02-08 | — | — | EP | claimed |
| WO-2024068415-A1 | CO-STABILIZERS FOR HYDROXYPHENYL TRIAZINE STABILIZED POLYMERS | BASF SE (DE) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024052176-A1 | RHEOLOGY MODIFYING OF POLYMERS WITH A RADICAL INITIATOR AND THIOURETHANE | BASF SE (DE) | 2024-03-14 | — | — | WO | disclosed |
| US-20230272171-A1 | ADDITIVE MIXTURES FOR RHEOLOGY MODIFICATION OF POLYMERS | BASF SE (DE) | 2023-08-31 | — | — | US | disclosed |
| US-9309408-B2 | Additive concentrate and use thereof | HOLLAND COLOURS N.V. (NL) | 2016-04-12 | — | — | US | disclosed |
| US-9085689-B2 | Polylactic acid stereocomplex resin composition having improved crystallization rate and method for molding the same | LOTTE CHEMICAL CORPORATION (KR) | 2015-07-21 | — | — | US | disclosed |
| US-20140378595-A1 | POLYLACTIC ACID STEREOCOMPLEX RESIN COMPOSITION HAVING IMPROVED CRYSTALLIZATION RATE AND METHOD FOR MOLDING THE SAME | LOTTE CHEMICAL CORPORATION (KR) | 2014-12-25 | — | — | US | disclosed |
| EP-2816086-A1 | Polylactic Acid Stereocomplex Resin Composition having Improved Crystallization Rate and Method for Molding the same | Lotte Chemical Corporation (KR) | 2014-12-24 | — | — | EP | disclosed |
| EP-2305317-A1 | Terminal sterilization of prefilled containers | Becton Dickinson and Company (US) | 2011-04-06 | — | — | EP | disclosed |
| US-20100099808-A1 | ENVIRONMENTALLY FRIENDLY MATERIAL USED FOR MAKING PENS | BEIFA GROUP CO., LTD. (CN) | 2010-04-22 | — | — | US | disclosed |
| US-20090012466-A1 | Terminal Sterilization of Prefilled Containers | BECTON, DICKINSON AND COMPANY (US) | 2009-01-08 | — | — | US | disclosed |
| EP-1694368-A4 | TERMINAL STERILIZATION OF PREFILLED CONTAINERS | BECTON DICKINSON CO (US) | 2007-11-07 | — | — | EP | disclosed |
| EP-1694368-A2 | TERMINAL STERILIZATION OF PREFILLED CONTAINERS | Becton, Dickinson and Company (US) | 2006-08-30 | — | — | EP | disclosed |
| WO-2005058377-A2 | TERMINAL STERILIZATION OF PREFILLED CONTAINERS | BECTON, DICKINSON AND COMPANY (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050129569-A1 | Terminal sterilization of prefilled containers | BECTON, DICKINSON AND COMPANY | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230272171-A1 | ADDITIVE MIXTURES FOR RHEOLOGY MODIFICATION OF POLYMERS | TST, INMT, CD44 | HSPA5 3353/4885CYP2C19 1505/4885CYP2C9 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.